Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma
Mahmoud Mansour(Sheba Medical Center), Mahmoud N. Nagi(King Saud University), Mohammed A. Aljoufi(King Saud University), Khaled Alhosaini(University of Leicester), Ammar C. Al‐Rikabi(King Saud University)
Cited by 13
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation
|Pharmacological Research|2015|121
Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat
|BMC Complementary and Alternative Medicine|2013|105
Hepato-protective effect of rutin via IL-6/STAT3 pathway in CCl4-induced hepatotoxicity in rats
|Biological Research|2015|92